Rekombinanter Poliovirus Receptor Antikörper
-
- Target Alle Poliovirus Receptor (PVR) Antikörper anzeigen
- Poliovirus Receptor (PVR)
- Antikörpertyp
- Recombinant Antibody
-
Reaktivität
- Maus
-
Wirt
- Kaninchen
-
Klonalität
- Chimeric
-
Konjugat
- Dieser Poliovirus Receptor Antikörper ist unkonjugiert
-
Applikation
- ELISA, Flow Cytometry (FACS)
- Produktmerkmale
-
Original Species of Ab: Rat
Original Format of Ab: IgG2a
- Aufreinigung
- Purified antibody.
- Immunogen
- This antibody was raised by immunising rats with recombinant murine CD155, consisting of the entire ectodomain expressed as a HIS-tagged protein.
- Klon
- 3F1
- Isotyp
- IgG kappa
- Top Product
- Discover our top product PVR Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Target
- Poliovirus Receptor (PVR)
- Andere Bezeichnung
- CD155 (PVR Produkte)
- Synonyme
- PVR antikoerper, CD155 antikoerper, HVED antikoerper, NECL5 antikoerper, Necl-5 antikoerper, PVS antikoerper, TAGE4 antikoerper, 3830421F03Rik antikoerper, D7Ertd458e antikoerper, Taa1 antikoerper, Tage4 antikoerper, mE4 antikoerper, necl-5 antikoerper, poliovirus receptor antikoerper, PVR antikoerper, Pvr antikoerper
- Hintergrund
- TAGE 3F1, Poliovirus receptor, cellular receptor for poliovirus, Pvr, Tumor-associated antigen 1, Taa1, Tage4, HVED
- UniProt
- Q8K094
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Cancer Immune Checkpoints, SARS-CoV-2 Protein Interaktom
-